Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 062690
Company: GLAXOSMITHKLINE
Company: GLAXOSMITHKLINE
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TICAR | TICARCILLIN DISODIUM | EQ 3GM BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/19/1986 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
07/03/1996 | SUPPL-6 | Manufacturing (CMC) |
Label is not available on this site. |
||
07/03/1996 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/26/1993 | SUPPL-3 | Labeling |
Label is not available on this site. |
||
02/26/1990 | SUPPL-2 | Manufacturing (CMC) |
Label is not available on this site. |